What to expect from PEGS Europe 2023: Day 3
Drug Discovery World
NOVEMBER 13, 2023
Oliver Hartley, PhD, Vice President, Drug Discovery, Orion Biotechnology, on: ‘Targeting small protein GPCRs by engineering their natural ligands’. Stefano Cucuzza, PhD, Postdoctoral Researcher, TRD Biologics & CGT, Novartis Pharma, on: ‘Not the usual suspects: Alternative surfactants for biopharmaceuticals’.
59 
Let's personalize your content